Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023
Oncotarget · 28.04.2026 · 17 (1) · 216-225
DOI: 10.18632/oncotarget.28877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncotarget, erschienen am 28.04.2026. Verfasst von Navkirat Kahlon und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Multiple Myeloma, Molecular Targeted Therapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Kahlon, N., Bansal, N., Baddam, S., Rajput, J., & Qureshi, Z. (2026). Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023. Oncotarget, 17(1), 216-225. https://doi.org/10.18632/oncotarget.28877
Vancouver
Kahlon N, Bansal N, Baddam S, Rajput J, Qureshi Z. Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023. Oncotarget. 2026;17(1):216-225. doi:10.18632/oncotarget.28877
BibTeX
@article{Kahlon2026,
author = {Kahlon, Navkirat and Bansal, Nahush and Baddam, Sujatha and Rajput, Jaisingh and Qureshi, Zaheer},
title = {Targeted therapeutics and U.S. population-level mortality trends in multiple myeloma: A SEER-based analysis from 1975 to 2023},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {216--225},
doi = {10.18632/oncotarget.28877}
}
EUVIMED